Sector pending / Health ServicesUpdated 2026-05-10 22:07 UTC

BVL/CVS stock hub

BVL/CVS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVL/CVSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

397.8B

Lima Stock Exchange

Market data

Price

Recent price action with selectable time range.

BVL/CVSBVL/CVS

—

Loading chart…

In the news

Latest news · BVL/CVS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.9

P25 n/aP50 n/aP75 n/a

Trailing P/E38.9

P25 n/aP50 n/aP75 n/a

ROE3.8

P25 n/aP50 n/aP75 n/a

ROIC6.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVL/CVS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	PE
Employees	259,500
Employees Change	0%
Employees Change Percent	0
Enterprise value	$627.5B
Exchange	Lima Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Health Services
Last refreshed	2026-05-10
Market cap	$397.8B
Price	$82
Price currency	USD
Rev Per Employee	5,456,539.02x
Sic	8000
Symbol	bvl/CVS
Website	https://www.cvshealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.57%
EV Earnings	61.31x
EV/EBIT	16.81x
EV/EBITDA	9.89x
EV/FCF	24.31x
EV/Sales	0.45x
FCF yield	6.49%
Forward P/E	11.86x
P/B ratio	1.47x
P/E ratio	38.87x
P/S ratio	0.28x
PE Ratio10 Y	23.11x
PE Ratio3 Y	36x
PE Ratio5 Y	30x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.67%
EBITDA Margin	3.8%
FCF margin	1.82%
Gross margin	13.39%
Gross Profit	$189.6B
Gross Profit Growth	6.44%
Gross Profit Growth Q	8.46%
Gross Profit Growth3 Y	0.51%
Gross Profit Growth5 Y	2.25%
Net Income	$10.2B
Net Income Growth	-44.47%
Net Income Growth Q	65.43%
Net Income Growth3 Y	-10.52%
Net Income Growth5 Y	-16.89%
Pretax Margin	0.85%
Profit Margin	0.72%
Profit Per Employee	$39,442
ROA	2.67
Roa5y	3.25
ROCE	6.51
ROE	3.75
Roe5y	7.3
ROIC	6.3
Roic5y	6.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	22.38%
Cagr3y	7.18%
Cagr5y	4.92%
EPS Growth	-45.23
EPS Growth Q	63.12
EPS Growth3 Y	-9.68
EPS Growth5 Y	-16.38
FCF Growth	24.46%
FCF Growth Q	-10.83%
FCF Growth3 Y	-24.81%
FCF Growth5 Y	-10.57%
OCF Growth	17.95%
OCF Growth Q	-6.74%
OCF Growth10 Y	1.54%
OCF Growth3 Y	-19.83%
OCF Growth5 Y	-7.73%
Revenue Growth	7.67x
Revenue Growth Q	6.15x
Revenue Growth3 Y	7.13x
Revenue Growth5 Y	8.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.6
Assets	$883.1B
Cash	$41.2B
Current Assets	$257.8B
Current Liabilities	$297.7B
Debt	$273.5B
Debt EBITDA	$4.25
Debt Equity	$1.01
Debt FCF	$10.6
Equity	$271B
Interest Coverage	3.49
Liabilities	$612.1B
Long Term Assets	$625.3B
Long Term Liabilities	$314.4B
Net Cash	$-232.3B
Net Cash By Market Cap	$-58.4
Net Debt EBITDA	$4.32
Net Debt Equity	$0.86
Net Debt FCF	$9
Tangible Book Value	$-115.5B
Tangible Book Value Per Share	$-90.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.87
Inventory Turnover	19.99
Net Working Capital	$-66B
Quick ratio	0.61
Working Capital	$-40.5B
Working Capital Turnover	$-104

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.07%
Payout Ratio	116.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	22.36%
200-day SMA	75.63
3Y total return	23.12%
50-day SMA	76.12
50-day SMA vs 200-day SMA	50over200
5Y total return	27.12%
All Time High	109.1
All Time High Change	-24.85%
All Time High Date	2022-02-04
All Time Low	44.04
All Time Low Change	86.19%
All Time Low Date	2024-12-30
ATR	0.42
Ch YTD	5.81
High	82
High52	82
High52 Date	2026-04-30
High52ch	0%
Low	82
Low52	59.02
Low52 Date	2025-07-30
Low52ch	38.94%
Ma50ch	7.73%
Price vs 200-day SMA	8.43%
RSI	96.65
RSI Monthly	57.42
RSI Weekly	66.6
Sharpe ratio	0.73x
Sortino ratio	1.29
Total Return	-1.07%
Tr YTD	7.62
Tr1m	9.57%
Tr1w	8.61%
Tr3m	1.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$37.9B
Operating Income Growth	16.19
Operating Income Growth Q	25.09
Operating Income Growth3 Y	-10.92
Operating Income Growth5 Y	-4.45
Operating margin	2.67

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,273,329,087%
Net Borrowing	-5,840,546,250
Shares Insiders	0.1%
Shares Institutions	91%
Shares Qo Q	0.16%
Shares Yo Y	1.07%
Short Ratio	2.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$23.5B
Average Volume	1.3x
Bv Per Share	212.4
CAPEX	$-10.3B
Ch1m	8.61
Ch1w	8.61
Ch1y	17.99
Ch3m	0.31
Ch3y	9.8
Ch5y	8.18
Ch6m	1.86
Change	0%
Change From Open	0
Close	82
Days Gap	0
Depreciation Amortization	15,736,740,250
Earnings Date	2026-08-05
EBIT	$37.9B
EBITDA	$53.8B
EPS	$8.01
F Score	6
FCF	$25.8B
FCF EV Yield	4.11x
Financing CF	-17,196,173,400
Fiscal Year End	December
Founded	1,963
Goodwill	294,535,818,500
Graham Number	51.49853
Graham Upside	-37.2
Income Tax	$1.9B
Investing CF	-20,886,054,700
Is Primary Listing	0
Last Earnings Date	2026-02-04
Last Report Date	2026-03-31
Lynch Fair Value	$10.55
Lynch Upside	-87.14
Ma150	77.84
Ma150ch	5.35%
Ma20	76.42
Ma20ch	7.31%
Net CF	-2,014,249,300
Next Earnings Date	2026-08-05
Open	82
P FCF Ratio	15.41
P OCF Ratio	11.03
Ppne	95,716,043,500
Price Date	2026-04-30
Price EBITDA	$7.39
Relative Volume	20x
Revenue	1,415,971,876,200x
SBC By Revenue	0.17x
Share Based Comp	2,356,357,500
Tax By Revenue	0.14x
Tax Rate	16.03%
Tr6m	3.61%
Z Score	2.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BVL/CVS pay a dividend?

Capital-return profile for this ticker.

Performance

BVL/CVS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVL/CVS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+91.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVL/CVS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

96.7

Above 70: short-term overbought

Price vs 200-day MA

+8.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.73

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVL/CVS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvl/CVS stock rating?

bvl/CVS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvl/CVS analysis?

The full report lives at /stocks/bvl/CVS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvl/CVS?

The latest report frames bvl/CVS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvl/CVS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.